Rammohan Devulapally

Head Senior Director, Non-Viral Delivery Granza Bio

Rammohan Devulapally, PhD is Senior Director and Head of Non-Viral Delivery at Granza Bio, where he leads development of targeted lipid nanoparticle (tLNP) platforms for in vivo genetic medicines and immune cell–specific delivery. With over 20 years of experience, he has advanced nanoparticle engineering from Stanford University research through multiple biotech leadership roles.

Seminars

Thursday 19th November 2026
Overcoming Barriers to T-Cell Delivery with Next-Generation LNPs
4:30 pm
  • Understand the key challenges limiting T-cell targeting and in vivo delivery
  • Explore emerging LNP designs and targeting strategies for improving delivery efficiency
  • Learn how next-generation delivery platforms are enabling new gene editing and immunotherapy applications
Rammohan Devulapally
View all Speakers
View Event Brochure